Holen Sie sich die Stockscreener-App
1.985
1.28%
0.025
Schlusskurs vom Vortag:
$1.96
Offen:
$1.91
24-Stunden-Volumen:
2.50M
Relative Volume:
0.73
Marktkapitalisierung:
$448.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-283.26M
KGV:
-1.3503
EPS:
-1.47
Netto-Cashflow:
$-273.61M
1W Leistung:
+16.08%
1M Leistung:
+14.74%
6M Leistung:
-23.95%
1J Leistung:
-75.97%
1-Tages-Spanne:
$1.81
$2.00
1-Wochen-Bereich:
$1.625
$2.0999
52-Wochen-Spanne:
$1.26
$8.31
Sana Biotechnology Inc Stock (SANA) Company Profile
Firmenname
Sana Biotechnology Inc
Sektor
Branche
Telefon
(206) 701-7914
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Vergleichen Sie SANA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
1.99 | 401.49M | 0 | -283.26M | -273.61M | -1.47 |
|
ONC
Beigene Ltd Adr
|
239.03 | 23.78B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.73 | 108.15B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.2548 | 43.44M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
597.07 | 61.69B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.16 | 5.72B | 0 | -153.72M | -103.81M | -2.00 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-18 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-11-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-01-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-08-14 | Eingeleitet | TD Cowen | Market Perform |
| 2023-05-02 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-03-01 | Eingeleitet | BofA Securities | Buy |
| 2021-03-01 | Eingeleitet | Goldman | Neutral |
| 2021-03-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-03-01 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Business Wire
Levi & Korsinsky Notifies Shareholders of Sana Biotechnology, Inc.(SANA) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment - Seeking Alpha
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, ... - Eagle-Tribune
SANA DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire
Sana Biotechnology, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - marketscreener.com
The End Of The Diabetes Industry?Eli Lilly (NYSE:LLY), DexCom (NASDAQ:DXCM) - Benzinga
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
Join Class Action to Recover Losses from Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire
Contact Levi & Korsinsky by May 20, 2025 to Join Class Action Against Sana Biotechnology, Inc. (SANA) - ACCESS Newswire
Investors in Sana Biotechnology, Inc. (SANA): Protect Your RightsContact Levi & Korsinsky Before May 20, 2025 - ACCESS Newswire
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit ... - Bluefield Daily Telegraph
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
2025-05-17 | Securities Class Action Lawsuit Filed Against Sana Biotechnology, Inc. (SANA)Levi & Korsinsky Represents Shareholders | NDAQ:SANA | Press Release - Stockhouse
SANA Deadline: Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
SANA Deadline: SANA Investors with Losses in Excess of $100K Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
2025-05-16 | Join Class Action to Recover Losses from Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky Before May 20, 2025 | NDAQ:SANA | Press Release - Stockhouse
Sana Biotechnology Inc (SANA) Should Be Considered For The Next Few Weeks - Stocksregister
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. LawsuitSANA - WV News
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
May 20, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SANA - Eagle-Tribune
Sana Biotechnology, Inc. (SANA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of May 20, 2025 Deadline - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - StreetInsider
Investors in Sana Biotechnology, Inc. Should Contact The Gross Law Firm Before May 20, 2025 to Discuss Your RightsSANA - WV News
Dimensional Fund Advisors LP Buys 478,596 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
May 20, 2025 Deadline Approaching: Join Class Action Against Sana Biotechnology, Inc. (SANA)Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Before May 20, 2025Contact Levi & Korsinsky - Stockhouse
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Morningstar
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - GlobeNewswire Inc.
SANA Lawsuit Alert! Class Action Lawsuit Against Sana Biotechnology, Inc. - TipRanks
Sana Biotechnology, Inc. (NASDAQ: SANA) Investor Alert: Deadline in Lawsuit on May 20, 2025 - openPR.com
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025SANA - ACCESS Newswire
What Is The Outlook For Sana Biotechnology Inc (NASDAQ: SANA) Like For Short-Term? - Stocksregister
Class Action Filed Against Sana Biotechnology, Inc. (SANA) Seeking Recovery for InvestorsContact Levi & Korsinsky - PR Newswire
Hsbc Holdings PLC Increases Stake in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Sana Biotechnology Reports Improved Quarterly Loss - TipRanks
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain OfficersSANA - PR Newswire
Sana Biotechnology, Inc. Class Action: The Gross Law Firm - GlobeNewswire
Sana Biotechnology, Inc. Class Action: The Gross Law Firm Reminds Sana Biotechnology, Inc. ... - Eagle-Tribune
Wells Fargo & Company MN Has $101,000 Stake in Sana Biotechnology, Inc. (NASDAQ:SANA) - Defense World
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the - GlobeNewswire
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit ... - Bluefield Daily Telegraph
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - GlobeNewswire Inc.
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA - ACCESS Newswire
2025-05-10 | Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your RightsSANA | NDAQ:SANA | Press Release - Stockhouse
Sana: Q1 Earnings Snapshot - New Haven Register
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sana Biotechnology Inc-Aktie (SANA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
1.40%
8.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):